These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 16504759

  • 1. SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.
    Cuneo KC, Geng L, Tan J, Brousal J, Shinohara ET, Osusky K, Fu A, Shyr Y, Wu H, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1197-203. PubMed ID: 16504759
    [Abstract] [Full Text] [Related]

  • 2. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.
    Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE.
    Cancer Res; 2004 Jul 15; 64(14):4893-9. PubMed ID: 15256460
    [Abstract] [Full Text] [Related]

  • 3. Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
    Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE, Lu B.
    Oncogene; 2005 Aug 18; 24(35):5414-22. PubMed ID: 15940265
    [Abstract] [Full Text] [Related]

  • 4. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
    Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M.
    Cancer Res; 2005 Sep 15; 65(18):8339-49. PubMed ID: 16166311
    [Abstract] [Full Text] [Related]

  • 6. Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.
    Lu B, Geng L, Musiek A, Tan J, Cao C, Donnelly E, McMahon G, Choy H, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):844-50. PubMed ID: 14967441
    [Abstract] [Full Text] [Related]

  • 7. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.
    Am J Physiol Endocrinol Metab; 2009 Jun 01; 296(6):E1440-9. PubMed ID: 19351806
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of Src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteries.
    Kox M, Wijetunge S, Pickkers P, Hughes AD.
    Vascul Pharmacol; 2007 Mar 01; 46(3):195-200. PubMed ID: 17113356
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo.
    Arai R, Tsuda M, Watanabe T, Ose T, Obuse C, Maenaka K, Minami A, Ohba Y.
    Eur J Cancer; 2012 Oct 01; 48(15):2417-30. PubMed ID: 22244830
    [Abstract] [Full Text] [Related]

  • 10. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
    Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1220-32. PubMed ID: 15519795
    [Abstract] [Full Text] [Related]

  • 11. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
    Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE, Lu B.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1536-43. PubMed ID: 16863930
    [Abstract] [Full Text] [Related]

  • 12. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R.
    Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869
    [Abstract] [Full Text] [Related]

  • 13. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
    Ischenko I, Guba M, Yezhelyev M, Papyan A, Schmid G, Green T, Fennell M, Jauch KW, Bruns CJ.
    Angiogenesis; 2007 Mar 15; 10(3):167-82. PubMed ID: 17486419
    [Abstract] [Full Text] [Related]

  • 14. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
    Sonveaux P, Brouet A, Havaux X, Grégoire V, Dessy C, Balligand JL, Feron O.
    Cancer Res; 2003 Mar 01; 63(5):1012-9. PubMed ID: 12615716
    [Abstract] [Full Text] [Related]

  • 15. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B, Ni J, Vatish M, Singer DR.
    Microcirculation; 2008 Apr 01; 15(3):251-67. PubMed ID: 18386220
    [Abstract] [Full Text] [Related]

  • 16. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
    Schueneman AJ, Himmelfarb E, Geng L, Tan J, Donnelly E, Mendel D, McMahon G, Hallahan DE.
    Cancer Res; 2003 Jul 15; 63(14):4009-16. PubMed ID: 12873999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D, Okamura M, Yoshimi H, Yamori T.
    Eur J Cancer; 2009 Mar 15; 45(5):857-65. PubMed ID: 19144509
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Horm Metab Res; 2013 Jun 15; 45(6):408-14. PubMed ID: 23386415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.